Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and retweets decide which stories make it beyond your newsfeed and onto our blog.
This month, we bring you: a discussion of the impact of eClinical technology, an interview with two oncologists about cancer clinical trials, and an investigation into the potential of smartphones to serve as a clinical data collection tool. Take a look, and tune in for the next roundup in a month!
1. eClinical technology in Asia Pacific
Clinical research is a notoriously long and expensive process. Last month, against this backdrop, BioSpectrum published an interview with professionals in clinical technology and drug development about the state of the eClinical market and and the positive impact of eClinical tools on clinical trials. The discussion focuses on Asia Pacific, where the eClinical market is growing fastest. Topics discussed in the interview include a breakdown of how eClinical-equipped trials are conducted, eClinical trends, and reasons Asia is seen as an ideal region for eClinical adoption. The subjects also discuss some of the challenges the industry faces related to eClinical technology.
2. Oncology clinical research from an expert perspective
Oncology is among the largest therapeutic areas in healthcare today, making cancer clinical trials more important than ever. We recently shared an interview with two oncologists who offer their insight into various facets of cancer research. These include aspects of how these trials work – typical trial duration and the informed consent process enter into the conversation – but also some important aspects of the patient experience: the oncologists discuss the benefits of clinical trial participation, as well as growing awareness of clinical trials among the general population.
3. The role of smartphones in Parkinson’s trials
The use, or potential use, of wearables and mobile technology in clinical trials has been a popular industry topic for some time. Against this backdrop, a recent study investigated the potential of smartphones to collect data in a way that could be particularly beneficial to Parkinson’s Disease clinical trials. The study found that data collected this way is often much more comprehensive and detailed than data collected via traditional methods. The findings were encouraging for a research area that faces its share of unique challenges.
That’s all for this roundup! We’ll have three more stories for you next month. In the meantime, check out this blog every week for new insights into EDC and clinical research.